Latest stem cell news and commentary

ISSCR 2014: Awards for Public Service

We would like to offer our warmest congratulations to Paolo Bianco, MD, Sapienza University of RomeElena Cattaneo, PhD, University of Milan, and Michele De Luca, MD, University of Modena and Reggio Emilia, who received their ISSCR Public Service Award on the 18th of June at the ISSCR Annual Meeting in Vancouver. 

ISSCR 2014: Catch up on the action!

By all accounts, ISSCR's annual meeting 2014 in Vancover (118-21 June) was a vibrant and stimulating conference. 

Science In the City of Copenhagen

From June 21 to 26, the Danish Stem Cell Center (DanStem) coordinated an exhibition and outreach event on Stem Cell Research as part of the Science in the City Festival in Copenhagen.

Danish visit to The Centre for Regenerative Medicine

 Playing 'Start as a stem cell'Playing 'Start as a stem cell'A discovery visit to Edinburgh during their Easter break saw twenty six students and their two teachers visiting The Centre For Regenerative Medicine. As a break from the delights of the city centre, the students from Stenhus Gymnasium were introduced to the stem cell research at the centre through a range of activities described here in English and Danish by Mikkel & Alexander:

Bumper crop of factsheet translations in EuroStemCell

This month sees a bumper crop of new factsheet translations going live on the EuroStemCell website!  Did you know we aim to have our content available in English, Spanish, French, German, Polish and Italian - making our work accessible to 80% of European citizens? 

New study raises doubts over the benefits of heart stem cell therapy

Summary

Numerous clinical trials have attempted to test the benefits of using a patient’s own stem cells (taken from the bone marrow) to treat heart disease. Results have been conflicting; some claim significant improvements in heart function, whilst others report none at all. A group at Imperial College London investigated the possible reasons for this inconsistency and found strange, unexplained discrepancies within reports of many of the clinical trials. They have identified a link between claimed success rates and discrepancies, casting doubts over the validity of this treatment.

- 133 reports of 49 clinical trials were investigated
- 600+ discrepancies were found
- Discrepancies ranged from minor to serious mistakes and misrepresentation of data
- Reports with the most discrepancies claimed most benefit to patients, while those without discrepancies showed no improvement in patients’ conditions 

Nature commentaries tackle current issues in regulation of stem cell therapies

Two recent opinion pieces in Nature highlight important social, ethical and regulatory issues around stem cell research. 

Spotlight on...stem cells and industry

This month we take a closer look at stem cells outside of the academic world, and their role in industry and commercialisation

Over the past four years we've developed and collected lots of information and resources about different aspects of stem cell research. This month we turn the spotlight on stem cells and industry

European Commission replies to petition against funding for research involving human embryos

The European Commission has responded to a European Citizens’ Initiative petition, reiterating its previous stance on the importance of embryonic stem cell research and potential treatments, while highlighting the existence of its ‘triple lock’ responsible research system.

Research from our partners: ethical issues, stem cell research and gastroenterology

In “Human stem-cell research in gastroenterology: experimental treatment, tourism and biobanking”, EuroStemCell ethics expert and Professor Emeritus of Lund University’s Department of Medical Ethics Göran Hermerén outlines some of the prospects for applying stem cell therapies to gastroenterological diseases, and related ethical issues.

Syndicate content